Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | Platform: GPL19057 | Kevin C sek | ||||||
GSE225526 |
Overexpression of FOXO1 enhances CAR T cell polyfunctionality, metabolic fitness and efficacy against solid tumors [Mouse RNAseq]
|
8 | Kevin C sek | Jan 18, 2024 | ||||
GSE225527 |
Overexpression of FOXO1 enhances CAR T cell polyfunctionality, metabolic fitness and efficacy against solid tumors
|
54 | Kevin C sek | Jan 18, 2024 | ||||
GSE230135 |
A2AR-eGFP reporter mouse enables elucidation of A2AR expression dynamics during anti-tumor immune responses
|
12 | Kevin C sek | Oct 03, 2023 | ||||
GSE237967 |
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (AT3 ATAC-Seq)
|
8 | Kevin C sek | Jul 24, 2023 | ||||
GSE237968 |
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (AT3 RNA-Seq)
|
12 | Kevin C sek | Jul 24, 2023 | ||||
GSE237969 |
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (CRISPR screen)
|
4 | Kevin C sek | Jul 24, 2023 | ||||
GSE237972 |
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (IRF1 ChIP-Seq)
|
8 | Kevin C sek | Jul 24, 2023 | ||||
GSE237973 |
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity (Mouse RNA-Seq)
|
12 | Kevin C sek | Jul 24, 2023 | ||||
GSE237974 |
A novel CRISPR/Cas9 screening platform identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and anti-tumor immunity
|
56 | Kevin C sek | Jul 22, 2023 |